- Home
- ECOR vs CCIF Comparison
ECOR vs CCIF Comparison
Compare ECOR & CCIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- CCIF
- Stock Information
- Founded
- ECOR 2005
- CCIF 2011
- Country
- ECOR United States
- CCIF United States
- Employees
- ECOR N/A
- CCIF N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CCIF Finance/Investors Services
- Sector
- ECOR Health Care
- CCIF Finance
- Exchange
- ECOR Nasdaq
- CCIF Nasdaq
- Market Cap
- ECOR 111.3M
- CCIF 110.5M
- IPO Year
- ECOR 2018
- CCIF N/A
- Fundamental
- Price
- ECOR $15.90
- CCIF $7.90
- Analyst Decision
- ECOR Strong Buy
- CCIF
- Analyst Count
- ECOR 1
- CCIF 0
- Target Price
- ECOR $25.00
- CCIF N/A
- AVG Volume (30 Days)
- ECOR 144.8K
- CCIF 76.9K
- Earning Date
- ECOR 03-12-2025
- CCIF 01-01-0001
- Dividend Yield
- ECOR N/A
- CCIF 25.90%
- EPS Growth
- ECOR N/A
- CCIF N/A
- EPS
- ECOR N/A
- CCIF N/A
- Revenue
- ECOR $23,327,000.00
- CCIF N/A
- Revenue This Year
- ECOR $59.81
- CCIF N/A
- Revenue Next Year
- ECOR $38.49
- CCIF N/A
- P/E Ratio
- ECOR N/A
- CCIF N/A
- Revenue Growth
- ECOR 74.10
- CCIF N/A
- 52 Week Low
- ECOR $5.32
- CCIF $7.43
- 52 Week High
- ECOR $18.67
- CCIF $10.16
- Technical
- Relative Strength Index (RSI)
- ECOR 53.73
- CCIF 45.64
- Support Level
- ECOR $15.50
- CCIF $7.62
- Resistance Level
- ECOR $16.12
- CCIF $8.06
- Average True Range (ATR)
- ECOR 1.20
- CCIF 0.13
- MACD
- ECOR -0.31
- CCIF -0.00
- Stochastic Oscillator
- ECOR 40.17
- CCIF 64.63
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing primarily in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting primarily of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.